These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 29861057)

  • 1. Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution-induced fibrosis.
    Raby AC; González-Mateo GT; Williams A; Topley N; Fraser D; López-Cabrera M; Labéta MO
    Kidney Int; 2018 Aug; 94(2):346-362. PubMed ID: 29861057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-Like Receptors 2 and 4 Are Potential Therapeutic Targets in Peritoneal Dialysis-Associated Fibrosis.
    Raby AC; Colmont CS; Kift-Morgan A; Köhl J; Eberl M; Fraser D; Topley N; Labéta MO
    J Am Soc Nephrol; 2017 Feb; 28(2):461-478. PubMed ID: 27432741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Toll-like receptor 4 in high-glucose-induced inflammatory and fibrosis markers in human peritoneal mesothelial cells.
    Choi SY; Ryu HM; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
    Int Urol Nephrol; 2017 Jan; 49(1):171-181. PubMed ID: 27722989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-based peritoneal dialysis fluids downregulate toll-like receptors and trigger hyporesponsiveness to pathogen-associated molecular patterns in human peritoneal mesothelial cells.
    Wu J; Yang X; Zhang YF; Wang YN; Liu M; Dong XQ; Fan JJ; Yu XQ
    Clin Vaccine Immunol; 2010 May; 17(5):757-63. PubMed ID: 20200188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C α inhibition prevents peritoneal damage in a mouse model of chronic peritoneal exposure to high-glucose dialysate.
    Wang L; Balzer MS; Rong S; Menne J; von Vietinghoff S; Dong L; Gueler F; Jang MS; Xu G; Timrott K; Tkachuk S; Hiss M; Haller H; Shushakova N
    Kidney Int; 2016 Jun; 89(6):1253-67. PubMed ID: 27142955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing Peritoneal Dialysis-Associated Fibrosis by Therapeutic Blunting of Peritoneal Toll-Like Receptor Activity.
    Raby AC; Labéta MO
    Front Physiol; 2018; 9():1692. PubMed ID: 30538643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CX3CL1-CX3CR1 interaction mediates macrophage-mesothelial cross talk and promotes peritoneal fibrosis.
    Helmke A; Nordlohne J; Balzer MS; Dong L; Rong S; Hiss M; Shushakova N; Haller H; von Vietinghoff S
    Kidney Int; 2019 Jun; 95(6):1405-1417. PubMed ID: 30948201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation, neoangiogenesis and fibrosis in peritoneal dialysis.
    de Lima SM; Otoni A; Sabino Ade P; Dusse LM; Gomes KB; Pinto SW; Marinho MA; Rios DR
    Clin Chim Acta; 2013 Jun; 421():46-50. PubMed ID: 23466603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage.
    Sandoval P; Loureiro J; González-Mateo G; Pérez-Lozano ML; Maldonado-Rodríguez A; Sánchez-Tomero JA; Mendoza L; Santamaría B; Ortiz A; Ruíz-Ortega M; Selgas R; Martín P; Sánchez-Madrid F; Aguilera A; López-Cabrera M
    Lab Invest; 2010 Oct; 90(10):1517-32. PubMed ID: 20531289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Therapeutic Potential of Human Umbilical Mesenchymal Stem Cells From Wharton's Jelly in the Treatment of Rat Peritoneal Dialysis-Induced Fibrosis.
    Fan YP; Hsia CC; Tseng KW; Liao CK; Fu TW; Ko TL; Chiu MM; Shih YH; Huang PY; Chiang YC; Yang CC; Fu YS
    Stem Cells Transl Med; 2016 Feb; 5(2):235-47. PubMed ID: 26718649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis.
    Liappas G; González-Mateo G; Aguirre AR; Abensur H; Albar-Vizcaino P; Parra EG; Sandoval P; Ramírez LG; Del Peso G; Acedo JM; Bajo MA; Selgas R; Sánchez Tomero JA; López-Cabrera M; Aguilera A
    Oncotarget; 2016 May; 7(21):30133-46. PubMed ID: 27102153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing peritoneal membrane fibrosis in peritoneal dialysis patients.
    Zhou Q; Bajo MA; Del Peso G; Yu X; Selgas R
    Kidney Int; 2016 Sep; 90(3):515-24. PubMed ID: 27282936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal Membrane Preservation.
    Bajo MA; Del Peso G; Teitelbaum I
    Semin Nephrol; 2017 Jan; 37(1):77-92. PubMed ID: 28153197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammalian Target of Rapamycin Complex 1 Activation Disrupts the Low-Density Lipoprotein Receptor Pathway: A Novel Mechanism for Extracellular Matrix Accumulation in Human Peritoneal Mesothelial Cells.
    Liu J; Zhu W; Jiang CM; Feng Y; Xia YY; Zhang QY; Xu PF; Zhang M
    Am J Nephrol; 2018; 48(5):357-368. PubMed ID: 30423569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis.
    Yokoi H; Kasahara M; Mori K; Ogawa Y; Kuwabara T; Imamaki H; Kawanishi T; Koga K; Ishii A; Kato Y; Mori KP; Toda N; Ohno S; Muramatsu H; Muramatsu T; Sugawara A; Mukoyama M; Nakao K
    Kidney Int; 2012 Jan; 81(2):160-9. PubMed ID: 21881556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfotanshinone IIA Sodium Ameliorates Glucose Peritoneal Dialysis Solution-Induced Human Peritoneal Mesothelial Cell Injury via Suppression of ASK1-P38-mediated Oxidative Stress.
    Zhou Y; He W; Sun W; Zhou Z; Sun M; Xia P; Li W; Zheng M; Zhang L; Ni J; Gao K
    Cell Physiol Biochem; 2018; 46(6):2434-2444. PubMed ID: 29742502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of damage-associated molecular patterns HMGB1 and S100A8/A9 coupled with toll-like receptor-triggered monocyte activation are associated with inflammation in patients with myelofibrosis.
    De Luca G; Goette NP; Lev PR; Baroni Pietto MC; Marin Oyarzún CP; Castro Ríos MA; Moiraghi B; Sackmann F; Kamiya LJ; Verri V; Caula V; Fernandez V; Vicente A; Pose Cabarcos J; Caruso V; Camacho MF; Larripa IB; Khoury M; Marta RF; Glembotsky AC; Heller PG
    Front Immunol; 2024; 15():1365015. PubMed ID: 39391311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertonic saline enhances host defense to bacterial challenge by augmenting Toll-like receptors.
    Chen LW; Huang HL; Lee IT; Hsu CM; Lu PJ
    Crit Care Med; 2006 Jun; 34(6):1758-68. PubMed ID: 16625117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dipeptide alanyl-glutamine ameliorates peritoneal fibrosis and attenuates IL-17 dependent pathways during peritoneal dialysis.
    Ferrantelli E; Liappas G; Vila Cuenca M; Keuning ED; Foster TL; Vervloet MG; Lopéz-Cabrera M; Beelen RH
    Kidney Int; 2016 Mar; 89(3):625-35. PubMed ID: 26880457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of allograft inflammatory factor-1 in the regulation of inflammation and oxidative stress in primary peritoneal mesothelial cells.
    Zhou Y; Li X; Yuan X; Hao L
    Cell Biol Int; 2019 May; 43(5):495-505. PubMed ID: 30761680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.